Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan ; volume:4 ; number:1 ; day:24 ; month:2 ; year:2005 ; pages:1-7 ; date:12.2005
Malaria journal ; 4, Heft 1 (24.2.2005), 1-7, 12.2005
- Creator
-
van den Broek, Ingrid
- Contributor
-
Amsalu, Ribka
Balasegaram, Manica
Hepple, Pamela
Alemu, Engudaye
Hussein, El Badri
Al-Faith, Muhammed
Montgomery, Jacqui
Checchi, Francesco
SpringerLink (Online service)
- DOI
-
10.1186/1475-2875-4-14
- URN
-
urn:nbn:de:1111-20160806291
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- van den Broek, Ingrid
- Amsalu, Ribka
- Balasegaram, Manica
- Hepple, Pamela
- Alemu, Engudaye
- Hussein, El Badri
- Al-Faith, Muhammed
- Montgomery, Jacqui
- Checchi, Francesco
- SpringerLink (Online service)
Other Objects (12)
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Efficacy of three artemisinin combination therapies for the treatmentof uncomplicated Plasmodium falciparum malaria in the Republic of Congo
Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar
Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children
Surveillance of artemisinin and partner drug efficacy in uncomplicated Plasmodium falciparum malaria in Coastal Kenya
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Mali: a systematic review and meta-analysis
Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials
Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Efficacy of three artemisinin combination therapies for the treatmentof uncomplicated Plasmodium falciparum malaria in the Republic of Congo
Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar
Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children
Surveillance of artemisinin and partner drug efficacy in uncomplicated Plasmodium falciparum malaria in Coastal Kenya
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Mali: a systematic review and meta-analysis
Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials
Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Efficacy of three artemisinin combination therapies for the treatmentof uncomplicated Plasmodium falciparum malaria in the Republic of Congo
Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar
Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children
Surveillance of artemisinin and partner drug efficacy in uncomplicated Plasmodium falciparum malaria in Coastal Kenya
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Mali: a systematic review and meta-analysis
Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials